Spruce Biosciences Stock Forecast

Stock Price Forecast

According to 9 analysts polled by S&P Global, Spruce Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $147.44. The average 1-year stock price forecast is 240.43% higher than the current stock price, while the lowest is $104 (+140.13%) and the highest is $230 (+431.06%).

Price Target: $147.44 (+240.43%)

Analyst Consensus: Strong Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$104	$147.44	$143	$230
Change	+140.13%	+240.43%	+230.18%	+431.06%

Analyst Ratings

The average analyst rating for Spruce Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	6	7	7	8	8	8
Buy	1	1	1	1	1	1
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	7	8	8	9	9	9

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Ram Selvaraju H.C. Wainwright	H.C. Wainwright	Buy Reiterates $150	Buy	Reiterates	$150	+246.34%	Nov 13, 2026
Madison Elsaadi B. Riley Securities	B. Riley Securities	Buy Reiterates $160	Buy	Reiterates	$160	+269.43%	Nov 10, 2026
Unknown Analyst Oppenheimer No rating	Oppenheimer	Buy Reiterates $230	Buy	Reiterates	$230	+431.06%	Nov 10, 2026
Albert Lowe Craig-Hallum	Craig-Hallum	Buy Maintains $140	Buy	Maintains	$140	+223.25%	Sep 30, 2026
Daniel Brims Lake Street	Lake Street	Buy Initiates $149	Buy	Initiates	$149	+244.03%	Sep 17, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

86.62M

EPS This Year

-31.04

from -50.83

EPS Next Year

0.91

from -31.04

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	10.09M	4.91M	-	-
Gross Profit	-	-35.20M	-39.34M	-41.51M	-13.62M	-
Gross Margin	-	-	-389.96%	-845.18%	-	90.00%
Operating Income	-42.07M	-47.28M	-51.99M	-56.15M	-28.61M	-71.76M
Net Income	-42.29M	-46.18M	-47.92M	-53.04M	-38.97M	-71.89M
EPS	-	-	-	-	-50.83	-31.04
Free Cash Flow	-	-	-	-	-	-67.16M
No. Analysts	-	-	-	-	-	9

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Chart

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Chart

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

Chart

EPS	2026	2027	2028
High	-28.46
Avg	-31.04
Low	-39.01

EPS Growth

Chart

EPS Growth	2026	2027	2028
High	-
Avg	-
Low	-